These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8853492)

  • 1. Prostate cancer screening with PSA, DRE and TRUS.
    Cusan L
    Can J Oncol; 1994 Nov; 4 Suppl 1():63-4. PubMed ID: 8853492
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison between 2 techniques of screening for prostatic carcinoma. Rectal exploration and transrectal ultrasonography vs. prostate specific antigen].
    Ciatto S; Bonardi R; Mazzotta A; Lombardi C; Santoni R; Cardini S; Zappa M
    Radiol Med; 1994 Oct; 88(4):453-7. PubMed ID: 7527916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic accuracy of transrectal ultrasonography for screening of prostatic cancer].
    Watanabe M; Saitoh M; Watanabe H
    Hinyokika Kiyo; 1996 Oct; 42(10):763-6. PubMed ID: 8951472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The digital rectal exam, prostate-specific antigen and transrectal echography in the diagnosis of prostatic cancer].
    Martínez de Hurtado J; Chéchile Toniolo G; Villavicencio Mavrich H
    Arch Esp Urol; 1995 Apr; 48(3):247-59. PubMed ID: 7538749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial.
    Labrie F; Candas B; Dupont A; Cusan L; Gomez JL; Suburu RE; Diamond P; Lévesque J; Belanger A
    Prostate; 1999 Feb; 38(2):83-91. PubMed ID: 9973093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening of prostate carcinoma].
    Trinkler FB
    Ther Umsch; 1995 Jun; 52(6):393-8. PubMed ID: 7541568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for prostate cancer.
    Waldman AR; Osborne DM
    Oncol Nurs Forum; 1994 Oct; 21(9):1513-7. PubMed ID: 7529409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of total PSA with a supersensitive PSA-assay during neo-adjuvant-chemotherapy of prostate cancer before radical resection of prostate.
    Spitz J; Enzmann T; Müller W; Weidenfeld M; Köllermann M
    Anticancer Res; 1999; 19(4A):2637-40. PubMed ID: 10470209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized strategy for detection of early stage, curable prostate cancer: role of prescreening with prostate-specific antigen.
    Labrie F; Dupont A; Suburu R; Cusan L; Gomez JL; Koutsilieris M; Diamond P; Emond J; Lemay M; Candas B
    Clin Invest Med; 1993 Dec; 16(6):425-39. PubMed ID: 7516831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening test for prostate cancer].
    Imai K; Kubota Y; Yamanaka H
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):1923-7. PubMed ID: 7522000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinico-echographic screening in the early diagnosis of prostatic carcinoma. Preliminary results of a feasibility study of a randomized trial].
    Ciatto S; Bonardi R; Mazzotta A; Lombardi C; Zappa M
    Radiol Med; 1993 Apr; 85(4):430-3. PubMed ID: 7685921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current role of echography, of PSA and of PSAD in the diagnosis of prostatic carcinoma].
    Pizzoccaro M; Valtorta A; Cappellano F; Sironi D; Catanzaro F
    Arch Ital Urol Androl; 1994 Sep; 66(4 Suppl):77-80. PubMed ID: 7534169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early detection of cancer of the prostate. Pros and cons].
    Hoesl CE; Altwein JE
    MMW Fortschr Med; 2005 Apr; 147(14):32, 34-6. PubMed ID: 15887681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
    Andriole GL; Levin DL; Crawford ED; Gelmann EP; Pinsky PF; Chia D; Kramer BS; Reding D; Church TR; Grubb RL; Izmirlian G; Ragard LR; Clapp JD; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Mar; 97(6):433-8. PubMed ID: 15770007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigen.
    Labrie F; Candas B; Cusan L; Gomez JL; Diamond P; Suburu R; Lemay M
    Urology; 1996 Feb; 47(2):212-7. PubMed ID: 8607237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryosurgery of prostate cancer. Use of adjuvant hormonal therapy and temperature monitoring--A one year follow-up.
    Lee F; Bahn DK; McHugh TA; Kumar AA; Badalament RA
    Anticancer Res; 1997; 17(3A):1511-5. PubMed ID: 9179188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate volume and cancer in screening programs.
    Standaert B; Alwan A; Nelen V; Denis L
    Prostate; 1997 Nov; 33(3):188-94. PubMed ID: 9365547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
    Men S; Cakar B; Conkbayir I; Hekimoglu B
    J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is a digital rectal examination necessary in the diagnosis and clinical staging of early prostate cancer?
    Philip J; Dutta Roy S; Ballal M; Foster CS; Javlé P
    BJU Int; 2005 May; 95(7):969-71. PubMed ID: 15839915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volume-adjusted prostate-specific antigen (PSA) variables in detecting impalpable prostate cancer in men with PSA levels of 2-4 ng/mL: transabdominal measurement makes a significant contribution.
    Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y
    BJU Int; 2005 Jun; 95(9):1245-8. PubMed ID: 15892809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.